Sign in
8-K

Current Report

Cellectar Biosciences, Inc. Filed Acc 0001144204-12-050930

Material agreement · Shareholder rights changed

  • Item 1.01 Entry into a material definitive agreement
  • Item 3.03 Material modification to rights of security holders

From the SEC's structured data for this filing

Loading v323564_8k.htm…